in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
API business of Dr. Reddy’s reports fall in sales
9:11 AM MDT | July 30, 2014 | Deepti Ramesh
The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 5.6% fall in sales in the company’s fiscal first quarter, ended 30 June, compared with the year-ago quarter, to 5.53 billion Indian rupees ($92 million). Earnings figures for the PSAI business have not been disclosed. Europe accounted for about 48% of the company's PSAI sales in the first quarter, North America accounted for 10%, India accounted for 14%, and the rest of the world accounted for 28%, Dr. Reddy’s says. During...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee